resveratrol has been researched along with srt1460 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bemis, JE; Boss, O; Carney, DP; Choy, W; Disch, JS; Elliott, PJ; Gagne, DJ; Galonek, H; Iffland, A; Israelian, K; Jin, L; Jirousek, MR; Lambert, PD; Lavu, S; Lynch, AV; Medvedik, O; Milne, JC; Ng, PY; Nunes, JJ; Olefsky, JM; Perni, RB; Schenk, S; Sinclair, DA; Smith, JJ; Vu, CB; Westphal, CH; Xie, R; Yang, H | 1 |
Bemis, JE; Carney, DP; Disch, JS; Gagne, DJ; Jirousek, MR; Lambert, PD; Lavu, S; Lynch, AV; Milne, JC; Ng, PY; Nunes, JJ; Olefsky, JM; Perni, RB; Schenk, S; Smith, JJ; Vu, CB | 1 |
Chen, D; Chen, K; Chen, L; Chen, X; Jiang, H; Li, J; Liu, D; Liu, H; Ning, C; Wang, J; Wu, J; Yu, N; Zhang, D; Zhao, F | 1 |
Ahn, K; Bleasdale, JE; Chrunyk, B; Cunningham, D; Flynn, D; Garofalo, RS; Griffith, D; Griffor, M; Loulakis, P; Pabst, B; Pacholec, M; Qiu, X; Stockman, B; Thanabal, V; Varghese, A; Ward, J; Withka, J | 1 |
Armour, SM; Blum, CA; Case, AW; Considine, T; Dai, H; Disch, JS; E, SY; Ellis, JL; Gomes, AP; Hamuro, Y; Howitz, KT; Hubbard, BP; Jiang, Y; Lamming, DW; Lee, JE; Li, J; Ling, AJ; Michan, S; Moss, J; Ng, PY; Pentelute, BL; Perni, RB; Riera, TV; Rolo, AP; Schuman, ER; Sinclair, DA; Stevens, LA; Sweitzer, SM; Vlasuk, GP; Zhao, H | 1 |
5 other study(ies) available for resveratrol and srt1460
Article | Year |
---|---|
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
Topics: Acetylation; Allosteric Site; Animals; Blood Glucose; Caloric Restriction; Catalytic Domain; Cell Line; Diabetes Mellitus, Type 2; Dietary Fats; Disease Models, Animal; Drosophila melanogaster; Heterocyclic Compounds, 4 or More Rings; Humans; Insulin; Male; Mice; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Zucker; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2007 |
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Activators; Hypoglycemic Agents; Imidazoles; Mice; Quinoxalines; Rats; Rats, Zucker; Sirtuin 1; Structure-Activity Relationship; Thiazoles | 2009 |
Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.
Topics: Acetylation; Fluorescent Dyes; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Sirtuin 1; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2013 |
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.
Topics: Acetylation; Allosteric Regulation; Animals; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Dietary Fats; Enzyme Activation; Enzyme Inhibitors; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Obese; Nuclear Magnetic Resonance, Biomolecular; Resveratrol; Rhodamines; Sirtuin 1; Stilbenes; Substrate Specificity; Surface Plasmon Resonance; Tumor Suppressor Protein p53 | 2010 |
Evidence for a common mechanism of SIRT1 regulation by allosteric activators.
Topics: Allosteric Regulation; Amino Acid Motifs; Amino Acid Sequence; Amino Acid Substitution; Animals; Cells, Cultured; Enzyme Activation; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutamic Acid; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Molecular Sequence Data; Myoblasts; Protein Structure, Tertiary; Resveratrol; Sirtuin 1; Stilbenes; Substrate Specificity | 2013 |